Veterinary POC Diagnostic Market-trends, demand, news, growth by 2027

 

Market Highlights

According to MRFR analysis, the Global Veterinary POC Diagnostic Market is expected to register a CAGR of 8.9% during the forecast period of 2020 to 2027 and reach USD 2,894 Million by 2027.

Changes in veterinary healthcare system like Point-of-Care (POC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/10018

The growth of the global veterinary POC diagnostic market can be attributed to the growing need for rescue medication, demand for POC diagnostic in the field of veterinary as the diseases in animals is increasing and affecting the human being as well.

Furthermore, growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for pet insurance & growing animal health expenditure, an increasing number of veterinary practitioners, increase in income levels in developed economies are expected to fuel the market growth during the forecast period.

However, the increasing pet care costs and high cost of veterinary imaging instruments are expected to restrain the growth of the global veterinary POC diagnostic market.

Several market players such as IDEXX Laboratories, Heska Corporation, and Fujifilm among others currently dominate the global veterinary POC diagnostic market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions, for instance, In January 2020, IDEXX launched the Vcheck Feline NT-proBNP test kit, In January 2020, Heska Corporation acquired SCIL Animal Care Company (Germany) to complement the company's veterinary diagnostics portfolio and expand the geographic portfolio across North America and greater Europe and reach over to 25 countries across these regions., In July 2019, Fujifilm Corporation established FUJIFILM VET Systems Co., Ltd in Japan to supply its veterinary products segment to veterinary clinical practices in the country. This expansion would enhance the company's veterinary medicine business in Japan. In January 2018, IDEXX launched the IDEXX Catalyst SDMA Test.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/veterinary-poc-diagnostic-market-10018

Segmentation

Global Veterinary POC Diagnostic Market has been segmented based on the Product, Technology, Application, Animal Type, and End User.

Based on the type, the global veterinary POC diagnostic market has been segmented into Consumable, Instruments. The consumable segment is expected to hold the largest market share owing to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases.

On the basis of technology, the market has been segmented into Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, and Molecular Diagnostics. Clinical Biochemistry is expected to hold a major market share due to the higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Based on the application, the market has been segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, and Neurology. Clinical pathology is expected to grow at the fastest CAGR.

The market based on end user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Based on the animal type, the market has been segmented into Companion animals, Livestock Animals. Clinical pathology is expected to grow at the fastest CAGR.

Key Players

Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising animal zoonotic diseases in the region. The veterinary POC diagnostic market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European veterinary POC diagnostic market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The veterinary POC diagnostic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing zoonotic diseases, the market in Asia-Pacific is expected to be the fastest-growing. The veterinary POC diagnostic market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

  

Global Demand on Neurology Devices Market Forecast to 2027

 

Market Highlights

According to MRFR analysis, the Global Neurology Devices Market is expected to register a CAGR of 10.2% during the forecast period of 2020 to 2027 and reach USD 21,029.7 Million by 2027.

Neurology devices are used for the treatment of neurological disorders that comprise pathophysiological conditions that affect the brain, spinal cord, and nervous system.

 

Get Free Sample @  https://www.marketresearchfuture.com/sample_request/9768

The market for neurology devices is expected to grow at boost due to a surge in the prevalence of the neurological disorder, a growing aging population, increasing adoption of technologically advanced devices, and growing demand for minimally invasive devices. However, high cost and stringent regulatory government regulations are some of the factors expected to hinder the growth of the market.

 

The global market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. As per the statistics of WHO in 2017, around 50 million people all over the world were affected by epilepsy. Additionally, Alzheimer's Research UK stated that over 50.8 million people worldwide were affected by dementia in 2017 and was expected to reach 55 million patients in 2020. Moreover, this number would double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. These huge prevalence of neurological disorders among the population and rising healthcare expenditure for neurological disorders are driving the growth of the neurology devices market.

 

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the increasing adoption of technological devices, favorable reimbursement scenarios, and the presence of major manufacturers among others. The neurology devices market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurology devices market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The neurology devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, the market in Asia-Pacific is expected to be the fastest-growing. The neurology devices market in the Middle East & Africa has been divided into the Middle East and Africa.

 

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/neurology-devices-market-9768 

 

 

Segmentation

 

The global neurology devices market has been segmented based on the product, and end user.

 

Based on product the market is segmented into neurostimulation, Interventional neurology, CSF management, and Neurosurgery devices. Neurostimulation segment accounted for the major market share owing to the increasing prevalence of epilepsy, Parkinson's disease, tremor, dystonia, depression, obsessive-compulsive disorder, Tourette syndrome, chronic pain, and cluster headache. The segment is further bifurcated by spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.

 

Interventional neurology segment is divided into aneurysm coiling & embolization (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting (carotid artery stents, filter devices, balloon occlusion devices), neurothrombectomy (clot retriever, suction aspiration devices, snares). Moreover, CSF management is further distributed into the following sub-segments, CSF shunts, and CSF drainage. The neurosurgery devices segment is further sub-segmented into ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips. The segment is expected to grow at the fastest CAGR during the forecast period owing to the increasing demand for non-invasive neurosurgery.

 

The market based on end users has been segmented into hospitals & clinics, specialty centers, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

 

 

Key Players

 

Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Global Hemorrhoid Treatment Devices Market Overview, Growth Analysis, Drivers and Top Company Profiles

 

Market Highlights

Global Hemorrhoid Treatment Devices Market is expected to have a market value of USD 973.94 Million by2025. Hemorrhoids, also called piles, are swollen and inflamed blood vessels in the anus as well as in the lower rectum. The global hemorrhoid treatment devices market is expected to grow at a steady rate owing to the increasing incidence rate of hemorrhoid cases and increasing initiatives by the public as well as private companies operating in the market. For instance, the number of people suffering from hemorrhoids in the US is currently estimated to be around 10.4 million; in addition, about 1 million new cases of hemorrhoids occur each year. Also, symptomatic hemorrhoids affect at least 50% of the population at some time during their lives.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8726

Regional Analysis

The global hemorrhoid treatment devices market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas led the market and accounted for the largest share in 2018, owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. Also, a favorable reimbursement scenario for hemorrhoid treatment surgeries is fueling the growth of this region in the hemorrhoid treatment devices market.

Europe accounts for the second-largest share in the global hemorrhoid treatment devices market. In 2018, 30% to 70% of adults were overweight in the European Union countries. Also, obesity affected 10% to 30% of adults in the European Union countries. Excess weight or pressure results in the constriction of veins and blood vessels surrounding the anus and colon. This increases the risk of developing hemorrhoids in obese individuals, thereby supporting the regional market growth.

Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the rising incidence of hemorrhoids and developing the healthcare sector in Asian countries, such as China, Japan, India, and Australia. Moreover, the increasing focus of big pharmaceutical companies to enter into this region is expected to drive the market growth.

The Middle East & Africa hemorrhoid treatment devices market is segmented into two major regions, namely the Middle East and Africa. The Middle East and Africa have fewer economic developments due to which the region accounts for the least market share but is expected to grow due to the growing demand for better treatments in these countries.

Access Report Details @ https://www.marketresearchfuture.com/reports/hemorrhoid-treatment-devices-market-8726

Segment Analysis

The global hemorrhoid treatment devices market has been segmented based on device type, procedure, and end-user. The market, based on device type, has been segmented into rubber band ligators, infrared coagulators, proctoscopes, anoscopes, doppler probes, cryotherapy devices, bipolar probes, and others. The market, based on procedure, has been categorized into rubber band ligation, sclerotherapy, infrared coagulation, and others. The market, based on end-user, has been divided into hospitals and clinics, ambulatory surgery centers, and others.

 

Key Players

MRFR recognizes the following companies as the Key Players in the Global Hemorrhoid Treatment Devices Market— Cook Medical (US), Medtronic plc (Ireland), Privi Medical (Singapore), Integra LifeSciences Corporation (Israel), Sklar Surgical Instruments (US), OBP Medical Corporation (US), CONMED Corporation (US), Boston Scientific Corporation (US), and Johnson & Johnson Services, Inc. (US).

Key Findings of the Study

The Global Hemorrhoid Treatment Devices Market is estimated to reach USD 973.94 Million by 2025 at a CAGR of 5.98% during the assessment period of 2019 to 2025.

The Americas accounted for the largest share of the global hemorrhoid treatment devices market due to the existence of medical device companies and the rising incidence rate of hemorrhoid cases, along with increased adoption of treatment by patients.

Based on the device type, the rubber band ligators segment accounted for the largest market share of 14% in 2018.

Based on the procedure, the rubber band ligation segment accounted for the largest market share of 39.2% in 2018.

On the basis of end-user, the hospitals and clinics segment accounted for the largest market share of 50.1% in 2018.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Airway Management Market Research Report, demand and Regional Forecast

 Market Highlights

According to MRFR analysis, Airway Management Market is expected to register a CAGR of 5.2% during the forecast period of 2019 to 2025 and is predicted to value USD 1,764.47 Million in 2025.

Download Free sample @ https://www.marketresearchfuture.com/sample_request/8472

Airway management plays an essential role in complex conditions. These devices and procedures are used for providing ventilation to the patients during surgical procedures, respiratory emergencies, and other medical procedures. For instance, lung cancer is the leading cause of death worldwide, with the estimated number of deaths caused by it in the year 2018 was approximately 9.6 million. Airway management has benefits that can resolve complications that may arise during the treatment of lung cancer and related disorders.

However, the low compatibility of airway management devices with patients is likely to hamper the growth of the global airway management market during the forecast period.

Several market players currently dominate the global airway management market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/airway-management-market-8472

Segmentation

The global airway management market has been segmented based on product type, application, and end user.

The market, based on product type, has been divided into supraglottic, infra-glottic, laryngoscopes, accessories, anesthesia masks, and others. The supraglottic segment is likely to hold the maximum market share in the global airway management market. Supraglottic are further segmented into laryngeal mask, nasopharyngeal, oropharyngeal, others.

On the basis of application, the global airway management market is segmented into general anesthesia, respiratory care, surgery, others. The end user segment of the market consists of surgical centers, hospitals, others. The hospital segment is expected to hold the largest share of the market as these centers are primary locations for the utilization of airway management products and services. As hospitals are primary medical facilities that use airway management devices and services the most. These products and services are used for patients undergoing surgeries, affected by respiratory emergencies and throat-related complications.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced airway management procedures. The Americas has been branched into North America and Latin America, with the North American market being further divided into the US and Canada.

The airway management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the fastest-growing market share owing to the increasing geriatric population and the rising adoption of technological advancements in developing regions. The European airway management market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The airway management market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

Some of the key players in the global airway management market are Vyaire Medical(US), Vbm Medizintechnik Gmbh (Germany), Roper Technologies (US) (Verathon Inc.), Sourcemark (US), Salter Labs (US), Ambu A/S. (Denmark), Intersurgical Inc (UK), Medtronic (Ireland), Smiths Group PLC (UK) (Smiths Medical), Teleflex Incorporated (US), and Sunmed (US).

Also Read @ https://www.medgadget.com/2020/07/covid-19-impact-on-airway-management-market-growth-2020-industry-analysis-size-estimation-top-company-share-regional-insights-demand-overview-forecast-to-2025.html 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Global Breast Imaging Market Overview, Growth Analysis, Drivers and Top Company Profiles

 

Market Synopsis

The global breast imaging market is considered to demonstrate 8.5% CAGR during the forecast period (2017-2023) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.

Get Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/5612

Drivers and Constraints Impacting the Market

With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the market growth. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have influenced the market growth to a great extent. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.

On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo breast imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.

Global Breast Imaging Market: Segmental Analysis

The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.

By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others. The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.

By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.

By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.

Regional Insights

Geographically, the breast imaging market span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.

The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.

The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.

Industry Updates

December 04, 2018: The Ultrasound Breast Imaging Center has opened in Walnut Creek. This ultrasound 3D breast imaging involves no compression, no radiation, and no injections.

Also Read Here!! https://www.medgadget.com/2021/02/breast-imaging-market-industry-analysis-2021-global-size-technology-demand-growing-segments-revenue-share-and-foster-market-growth-by-2025.html

Competitive Dashboard

The prominent players operating the global breast imaging market are Sonocine Inc. (U.S.), Fujifilm Holdings Corporation (Japan), General Electric Company (U.K.), Hologic Inc. (U.S.), Dilon Technologies Inc. (U.S.), Gamma Medica Inc. (U.S.), Toshiba Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), Aurora Imaging Technology Inc. (U.S.), and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/breast-imaging-market-5612

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Coma diagnosis & treatment Market Analysis, Growth, COVID19 Impact and Report

Market Highlights

There is no particular treatment that can cause someone to come out of a coma and treatments can prevent further physical and neurological damage. However depending on the cause of a coma, patient who are continuosly in this state for more than one year are extremely unlikely to awaken.

Over the last decade, the number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.

Increasing prevalence of neurological/brain disorder like epilepsy, rising need for better treatment, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology will fuel the market growth during the forecast period. On the other hand, higher cost of the treatment procedure may slow the market growth during the review period.

The global coma diagnosis & treatment market is expected to grow at a CAGR of ~7.1% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global coma diagnosis & treatment market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development.    

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy, and depression will have a positive impact on the growth of the market. The growing public awareness will boost the adoption of these devices in the European market. 

Asia Pacific is the fastest growing coma diagnosis & treatment market across the globe. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.     

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth. 

You can also Read @ https://www.medgadget.com/2018/08/coma-diagnosis-and-treatment-market-anticipated-to-witness-noteworthy-growth-in-the-coming-years.html

Segmentation

The global coma diagnosis & treatment market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into toxic- metabolic encephalopathy, anoxic brain injury, persistent vegetative state, locked-in syndrome, and brain death. On the basis of diagnosis it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). On the basis of treatment it is segmented into medical treatment, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.

Key Players

Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan),            Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Browse Full Report @ https://www.marketresearchfuture.com/reports/coma-diagnosis-and-treatment-market-4990

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Phototherapy Market Sales Revenue, Development Strategy, Gross Margin Analysis, Competitive Landscape and Demand

 

Market Overview

Global Phototherapy Market is expected to reach USD 764.5 Million by 2027, growing with a CAGR of 4.61% during the forecast period. Market Research Future (MRFR), in its report, offers an in-depth look into the market during the review period.

Get Free sample @ https://www.marketresearchfuture.com/sample_request/1844

Regional Analysis

Global Phototherapy Market has been studied in five key regions— Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas is expected to lead the market with a valuation of USD 227.1 million in 2019. The regional market value is projected to reach USD 326.3 million by 2027 at a 4.63% CAGR during the forecast period. The US and Canada are the key country-level markets in the Americas. The regional market growth is primarily driven by the high demand for phototherapy treatments in the region, which is likely to create additional opportunities for service providers operating in the phototherapy market in the Americas.

Europe is expected to be the second-largest market with an estimated value of USD 203.8 million in 2019 and a projected value of USD 298.8 million by 2027, registering a 4.90% CAGR during the forecast period. The European phototherapy market includes the UK, Germany, France, Italy, and the rest of Europe. The presence of prominent players such as Signify Holding and Herbert Waldmann GmbH & Co. KG are driving market growth in the region. Moreover, due to the increasing number of skin disease treatments, there will likely be an increased requirement for phototherapy in the region.

Asia-Pacific accounted for the third-largest market share in 2019. The region is expected to be the fastest-growing market for phototherapy during the review period. The Asia-Pacific phototherapy market covers China, Japan, India, Australia, and the rest of Asia-Pacific. The region is gaining prominence in the global healthcare industry and is projected to become the world’s leading market. Additionally, the increasing demand for skin treatments in the region is expected to drive the growth of the regional market. The regional phototherapy market is expected to reach USD 101.9 million by 2027.

The phototherapy market in the Middle East & Africa is expected to reach a valuation of USD 37.5 million by 2027. The regional market growth is significantly driven by the presence of major countries, such as the UAE, Saudi Arabia, and Israel. The region has witnessed notable economic growth in the past few years. One of the major factors driving the economy in the region is enhanced healthcare facilities. The demand for phototherapy is expected to increase due to the rapid increase in the number of skin treatments in the region.

Segmental Analysis

Extensive research has been conducted on the Global Phototherapy Market, which has been segmented by Product, Radiation, Application, and End User.

Based on product, the global phototherapy market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. The conventional phototherapy equipment segment is expected to dominate the market with an estimated valuation of USD 184.0 million in 2019, and the segment is also expected to register a higher CAGR of 3.94% during the forecast period.

By radiation, the global phototherapy market has been classified into UVA, UVB, and UVC. The UVB segment is expected to exhibit the highest CAGR of 5.26% during the forecast period.

By application, the global phototherapy market has been classified into skin disease treatment, neonatal jaundice management, and sterilization. The neonatal jaundice management segment is likely to exhibit the highest CAGR of 5.44% during the forecast period.

Based on end-user, the global phototherapy market has been segmented into hospital & clinic, dermatology center, and homecare. The hospital & clinic segment is expected to hold a larger market share and was valued at USD 378.0 Million in 2019.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/phototherapy-market-1844

Competitive Analysis

The Prominent Players profiled in the Global Phototherapy Market are Signify Holding (Netherlands), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).

Mergers, acquisitions, and collaborations are a few of the key growth strategies adopted by these companies to compete in the global market.

Key Developments

In July 2019, Strata Skin signed a contract with Kosmo Meditech, a distributor of medical devices based in South Korea. Under the contract, Kosmo Meditech will distribute Strata Skin Sciences, Inc.’s XTRAC in South Korea. The contract enabled the company to strengthen its position in the South Korean phototherapy market.

In August 2018, Strata Skin signed a marketing agreement with one of the US’s largest private equity-backed dermatology groups. Under the agreement, Strata Skin will provide XTRAC to the latter’s clinics. The agreement helped the company to strengthen its position in the market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Seasonal Affective Disorder Market Dynamics, Trends, Outlook And Segmentation

 Seasonal Affective Disorder Market Analysis 

The global seasonal affective disorder market is predicted to touch USD 694.9 million at a 4.2% CAGR by 2023, as per the latest Market Research Future (MRFR) report. Seasonal affective disorder or SAD is a form of depression which is associated with changes in seasons. It starts as well as ends within the same time of the year. Social withdrawal, loss of ability to concentrate, weight gain, increased appetite, and hopelessness are some of its major symptoms. 

Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.marketresearchfuture.com/sample_request/4123 

Various factors are propelling the seasonal affective disorder market growth. These factors, in accordance with the MRFR report, include growing awareness and increasing prevalence of the seasonal affective disorder, rising physician visits associated to this disorder, lack of exercise, changing lifestyle, and adoption and availability of new seasonal affective disorder treatments. Additional factors pushing market growth include an increase in geriatric population, technological development, improved distribution network, and favorable reimbursement scenario. 

On the contrary, higher preference for light therapy and expanding market for generic drugs are factors that may hinder the seasonal affective disorder market growth. 

Seasonal Affective Disorder Market Segmentation 

The MRFR report provides a complete segmental analysis of the seasonal affective disorder market report on the basis of type, treatment, diagnosis, and end user. 

Based on type, the seasonal affective disorder market is segmented into spring and summer SAD, fall and winter SAD, and others. 

Based on diagnosis, the seasonal affective disorder market is segmented into psychological evaluation, lab tests, physical exam, and others. The lab test segment is further segmented into thyroid blood tests, complete blood count, and others. The psychological evaluation segment is again segmented into direct observation tests, vocational tests, neuropsychological tests, aptitude tests, achievement tests, attitude tests, personality tests, and intelligence tests. 

Based on treatment, the seasonal affective disorder market is segmented into counselling, psychotherapy, medications, light therapy, and others. The medications segment has been further segmented into antidepressants and others. Antidepressants have been again segmented into reuptake inhibitors and others. The psychotherapy segment has further been segmented into gestalt therapy, existential psychotherapy, cognitive analytical therapy, body psychotherapy, behavioral therapy, attachment-based psychotherapy, art therapy, and others. 

Based on end user, the seasonal affective disorder market is segmented into medical research centers, academic institutes, hospitals and clinics, and others. 

Seasonal Affective Disorder Market Regional Analysis 

By region, the seasonal affective disorder market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period. This is owing to increasing awareness regarding different mental disorders and changing lifestyle. The US, South America, and Brazil are the key contributors in this region. 

The seasonal affective disorder market in Europe is predicted to have a healthy growth over the forecast period. This is owing to the rising prevalence of seasonal affective disorder and severe depression. The UK, Ireland, Germany, and France are the key contributors in this region. 

The seasonal affective disorder market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to growing awareness, changing lifestyle, availability of products and treatments, and developing health facilities. 

The seasonal affective disorder market in the Middle East and Africa will have a slow growth over the forecast period. This is owing to limited access to healthcare facilities, less awareness about seasonal affective disorder, and low prevalence rate. The countries in the Middle East are leading the market owing to rising expenditure on health and developed healthcare infrastructure. 

Seasonal Affective Disorder Market Key Players 

Key players profiled in the global seasonal affective disorder market report include Pfizer Inc. (US), Henry Schein, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Allergan (Republic of Ireland), and AbbVie Inc. (US). 

February 2019: Australia based medtech startup, Active Wearables has come up with a wearable, Pocket Sky that has been specially designed for combating conditions that result from poor access to sunlight and time shifts. This device can be used as glasses and emits blue light for emulating sunlight, and suppress melatonin production. Pocket Sky can aid with conditions which are based on restricted sunlight, including seasonal affective disorder and also problems with circadian rhythms, including shift work order and jetlag. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @  https://www.marketresearchfuture.com/reports/seasonal-affective-disorder-market-4123 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.